Brain Disease Modalities And Software Market Top Players - Vuno Co., Ltd., Fujifilm Holdings Corporation, Aspect Imaging, IXICO, QMENTA.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Disease Modalities And Software Market Size, Share & Trends Analysis Report By Product (Brain Imaging Modalities and Brain Analysis Software), By Type of Patients (Adults, Pediatrics and Infants), Region, Market Outlook And Industry Analysis 2034"

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1945

According to the latest research by InsightAce Analytic, the Global Brain Disease Modalities And Software Market is valued at 14.61 Billion in 2024, and it is estimated to reach 24.53 Billion by the year 2034, with a CAGR of 5.4 % during the forecast period of 2025-2034.

Brain disease diagnostics encompass a range of advanced imaging techniques, including Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Positron Emission Tomography (PET) scans, and hybrid imaging technologies such as PET-CT and PET-MRI systems. CT imaging captures cross-sectional images using X-ray technology, while MRI utilizes magnetic fields and radio waves to produce high-resolution anatomical visuals. These imaging modalities are critical in the identification and management of various neurological conditions, including cerebral oxygenation deficits, strokes, tumors, traumatic brain injuries, blood pressure irregularities, and overall brain function monitoring.

Imaging software significantly enhances the diagnostic process by enabling detailed analysis and quantification of brain scans. These tools provide statistical assessments of brain structures, detect biomarkers, and reveal subtle pathological changes, thereby improving diagnostic precision and supporting early intervention strategies for neurological disorders.

Market growth is fueled by continuous technological innovation-particularly the integration of artificial intelligence-along with the increasing prevalence of neurological conditions and growing demand for non-invasive diagnostic methods. Although neuroimaging volumes temporarily declined during the COVID-19 pandemic, the demand for respiratory-related imaging offered partial compensation. A notable challenge to market expansion is the global shortage of helium, an essential resource for MRI operations, which has impacted imaging system performance and availability. Additionally, the high cost of imaging equipment and associated procedures continues to limit accessibility, prompting some patients to seek alternative diagnostic solutions.

From a regional perspective, North America and Europe held the largest market shares in 2022, driven by established healthcare infrastructure and high diagnostic adoption rates. However, the Asia-Pacific region is projected to experience the fastest compound annual growth rate (CAGR) in the coming years, supported by rapid technological advancements, increased healthcare investments, and growing clinical adoption of advanced neuroimaging solutions.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01

Competitive Landscape
Some of The Key Players in The Brain disease modalities and software Market:
• Quantib
• Brainomix
• Qure.AI
• General Electric Company
• Imaging Biometrics, LLC
• United Imaging Healthcare Co. Ltd.
• Siemens
• Healthineers AG
• Koninklijke Philips N.V.
• Canon Inc.
• Vuno Co. Ltd.
• Aspect Imaging
• IXICO
• QMENTA
• Cortechs.ai
• A.I. Analysis Inc.
• Fujifilm Holdings Corporation
• Other Prominent Players.

Key developments
• In Mar 2023, Brainomix declared that the FDA had approved its Brainomix 360 e-ASPECTS tool for stroke, allowing the Oxford-based business to introduce its cutting-edge stroke AI imaging technology to US stroke facilities.
• In Jan 2022, Quantib introduced a substantial upgrade to its AI-powered solution for brain atrophy and white matter hyperintensity progression called Quantib® ND 2.0. This upgrade was made possible by the company's commitment to continuous research and development. The solution has been given authorization by the FDA for use in clinical settings in the United States.
• In Nov 2021, Siemens Healthineers Launches World's First CT Scanner 'NAEOTOM Alpha' With Photon-Counting Technology. The photon-counting technology enables drastic improvements in radiation dose by up to 45 percent rise in reduction and resolution for ultra-high resolution (UHR) scans compared with traditional CT detectors.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1945

Market Segments
Global Brain disease modalities and software Market segmented by Products, 2023-2031 (Value US$ Mn)
• Brain analysis software
 PET Devices
 CT Devices
 MRI Devices
 PET-CT
 PET-MRI
• Brain imaging modalities
Global Brain disease modalities and software Market segmented by Type of Patients, 2023-2031 (Value US$ Mn)
• Adults
• Pediatrics
• Infants
Global Brain disease modalities and software Market segmented by End-User, 2023-2031 (Value US$ Mn)
• Hospitals and clinics
• Ambulatory surgery centers
• Diagnostic imaging centers
Global Brain disease modalities and software Market segmented by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global protein design and engineering market
 To receive an industry overview and future trends of the protein design and engineering market
 To analyze the protein design and engineering market drivers and challenges
 To get information on the protein design and engineering market size (Value US$ Mn) forecast to 2031
 Significant investments, mergers & acquisitions in the protein design and engineering market industry

Read Overview Report- https://www.insightaceanalytic.com/report/brain-disease-modalities-and-software-market/1945

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.